Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| VKTX | CLUSTER | neutral | 3/10 | VKTX CFO and COO sold a combined $1.32M in open-market sales on July 29, 2026, at ~$33.47/share, following non-cash stoc | Jul 29, 2026 |
| SCTX | CLUSTER | bullish | 8/10 | A massive insider buying cluster at Scribe Therapeutics, with three directors and two C-suite officers purchasing a tota | Jul 29, 2026 |
| SCTX | CLUSTER | bullish | 8/10 | Director and 10% owner Behzad Aghazadeh purchased $35M of SCTX stock at $15/share, alongside smaller open-market buys by | Jul 28, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | CEO Robert Blum exercised 7,500 options at $10.60 and immediately sold the shares at $80.87 for $607K in proceeds, while | Jul 28, 2026 |
| INCY | CLUSTER | neutral | 3/10 | Two senior INCY executives (CMO and EVP of U.S. Commercial) sold a combined $341K of stock on July 16, 2026, while two o | Jul 27, 2026 |
| ONC | CLUSTER | neutral | 2/10 | CEO John Oyler and SVP/GC Lee Chan Henry executed a cluster of open-market sales totaling ~$5.4M over two days, with Oyl | Jul 25, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt sold $6.3M in open-market shares over two days (July 22-23), primarily to cover taxes on exercised | Jul 25, 2026 |
| IMVT | CLUSTER | neutral | 2/10 | Two C-suite insiders at Immunovant (CFO and CTO) sold a combined $374K in open-market sales on July 23, 2026, at $38.69 | Jul 24, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt sold $3.4M worth of UTHR shares across 9 open-market trades on July 22, 2026, at prices ranging fr | Jul 24, 2026 |
| ADPT | CLUSTER | neutral | 4/10 | Three C-suite executives at Adaptive Biotechnologies sold a total of $8.56M in shares over a one-week window. The sales | Jul 23, 2026 |
| MLYS | CLUSTER | neutral | 2/10 | Two C-suite insiders at Mineralys Therapeutics sold shares totaling ~$211K in open-market transactions after exercising | Jul 23, 2026 |
| GRML | CLUSTER | bullish | 7/10 | Three insiders at Greenland Mines Ltd (GRML), including CFO Jeff LeBlanc, purchased $326K in open-market shares over a 7 | Jul 23, 2026 |
| SGMT | CLUSTER | neutral | 4/10 | Three Sagimet insiders, including the CEO, sold a combined $719K in open-market sales over a 7-day window. The CEO's $49 | Jul 23, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | A minor insider selling cluster at UTHR, CEO Rothblatt and EVP/GC Mahon sold a combined $521K in open-market transaction | Jul 23, 2026 |
| LQDA | CLUSTER | bearish | 5/10 | A massive insider selling cluster at Liquidia Corp (LQDA) saw 10 insiders, including the CEO, CFO, and CCO, sell a total | Jul 22, 2026 |
| TOI | CLUSTER | neutral | 2/10 | A mixed insider cluster at Oncology Institute, Inc. (TOI) saw CMO Yale Podnos sell $116K in shares on July 14 while 10% | Jul 22, 2026 |
| ELVN | CLUSTER | neutral | 2/10 | Two C-suite insiders at Enliven Therapeutics (ELVN) sold a combined $127K in open-market transactions on July 17, 2026. | Jul 22, 2026 |
| UTHR | CLUSTER | bearish | 4/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined $2.72M in UTHR stock over a 7-day window. The CEO's sales follo | Jul 22, 2026 |
| INCY | CLUSTER | neutral | 2/10 | Two senior Incyte executives (CMO and EVP of U.S. Commercial) sold a combined $341K in open-market stock on July 16, 202 | Jul 21, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | A cluster of insider sales at United Therapeutics shows the CEO and General Counsel selling shares, primarily to cover t | Jul 21, 2026 |
| MLYS | CLUSTER | neutral | 3/10 | CEO Jon Congleton and CMO David Malcom Rodman sold a combined ~$302K in MLYS stock over a 7-day window, with the CEO's $ | Jul 20, 2026 |
| ADPT | CLUSTER | neutral | 2/10 | Two C-suite officers at Adaptive Biotechnologies sold a combined $2.5M in open-market sales over a 7-day window. The tot | Jul 20, 2026 |
| GRML | CLUSTER | bullish | 6/10 | Two insiders at Greenland Mines Ltd (GRML) purchased a combined $270K in open-market transactions over a 7-day window, l | Jul 20, 2026 |
| MLTX | CLUSTER | bearish | 4/10 | MoonLake Immunotherapeutics (MLTX) CEO and CSO sold a combined $1.69M of shares in open-market transactions over the pas | Jul 20, 2026 |
| MPLT | CLUSTER | neutral | 4/10 | A cluster of open-market share sales by five top executives at MapLight Therapeutics (MPLT) occurred over a two-week win | Jul 20, 2026 |
| GLUE | CLUSTER | neutral | 2/10 | President & CEO Markus Warmuth and COO Jennifer Champoux sold a combined $322K in open-market sales over two days, with | Jul 18, 2026 |
| CGON | CLUSTER | neutral | 2/10 | Two CG Oncology directors sold a combined $1.89M in stock over a 7-day window, with the bulk ($1.82M) sold by director J | Jul 18, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Three UTHR insiders (CEO, EVP & General Counsel, and a Director) sold shares in a cluster from July 9-16, 2026. The CEO | Jul 18, 2026 |
| ONC | CLUSTER | bearish | 5/10 | CEO John Oyler sold ~$43.2M in open-market shares on July 16-17 after exercising options, while SVP/General Counsel Lee | Jul 18, 2026 |
| MPLT | CLUSTER | neutral | 2/10 | Two senior insiders at MapLight Therapeutics, the General Counsel and Chief Medical Officer, executed open-market sales | Jul 17, 2026 |